Co-inhibition of EZH2 and the PI3K/AKT/mTORC1 pathway produced superior antitumor activity in both murine and human preclinical models of plastic PCa, especially in castration settings where AR signaling is suppressed. The gene discussed is AR; the disease is posterior cortical atrophy.